IL109396A - PYRIDO £1,2,3-de| QUINOXALINE-2,3- DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION - Google Patents

PYRIDO £1,2,3-de| QUINOXALINE-2,3- DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION

Info

Publication number
IL109396A
IL109396A IL109396A IL10939694A IL109396A IL 109396 A IL109396 A IL 109396A IL 109396 A IL109396 A IL 109396A IL 10939694 A IL10939694 A IL 10939694A IL 109396 A IL109396 A IL 109396A
Authority
IL
Israel
Prior art keywords
pct
quinoxaline
pyrido
processes
preparation
Prior art date
Application number
IL109396A
Other languages
English (en)
Other versions
IL109396A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL109396A0 publication Critical patent/IL109396A0/xx
Publication of IL109396A publication Critical patent/IL109396A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL109396A 1993-04-28 1994-04-22 PYRIDO £1,2,3-de| QUINOXALINE-2,3- DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION IL109396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314593A DE4314593A1 (de) 1993-04-28 1993-04-28 Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln

Publications (2)

Publication Number Publication Date
IL109396A0 IL109396A0 (en) 1994-07-31
IL109396A true IL109396A (en) 1997-11-20

Family

ID=6487060

Family Applications (1)

Application Number Title Priority Date Filing Date
IL109396A IL109396A (en) 1993-04-28 1994-04-22 PYRIDO £1,2,3-de| QUINOXALINE-2,3- DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION

Country Status (22)

Country Link
US (1) US5750526A (ko)
EP (1) EP0696291B1 (ko)
JP (1) JPH09500359A (ko)
KR (1) KR960701885A (ko)
CN (1) CN1043576C (ko)
AT (1) ATE169925T1 (ko)
AU (1) AU686160B2 (ko)
CA (1) CA2161427A1 (ko)
CZ (1) CZ277795A3 (ko)
DE (2) DE4314593A1 (ko)
DK (1) DK0696291T3 (ko)
ES (1) ES2122274T3 (ko)
FI (1) FI955141A (ko)
HU (1) HUT74173A (ko)
IL (1) IL109396A (ko)
NO (1) NO305439B1 (ko)
NZ (1) NZ265600A (ko)
PL (1) PL174418B1 (ko)
RU (1) RU2140924C1 (ko)
SK (1) SK131995A3 (ko)
WO (1) WO1994025472A1 (ko)
ZA (1) ZA942970B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2251857A1 (en) * 1996-04-17 1997-10-23 Tohru Tatsuno Remedy for retinal neuropathy
AU5704898A (en) * 1996-12-16 1998-07-15 Warner-Lambert Company Tricyclic quinoxaline derivatives as neuroprotective agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2051697C (en) * 1989-06-09 1996-10-08 Malcolm Wilson Moon Heterocyclic amines having central nervous system activity
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体

Also Published As

Publication number Publication date
AU6675694A (en) 1994-11-21
ATE169925T1 (de) 1998-09-15
CZ277795A3 (en) 1996-02-14
DK0696291T3 (da) 1999-05-25
NO305439B1 (no) 1999-05-31
AU686160B2 (en) 1998-02-05
CN1121720A (zh) 1996-05-01
NO954317L (no) 1995-12-28
PL174418B1 (pl) 1998-07-31
JPH09500359A (ja) 1997-01-14
RU2140924C1 (ru) 1999-11-10
WO1994025472A1 (de) 1994-11-10
PL311295A1 (en) 1996-02-05
ES2122274T3 (es) 1998-12-16
ZA942970B (en) 1995-01-19
DE59406739D1 (de) 1998-09-24
FI955141A0 (fi) 1995-10-27
DE4314593A1 (de) 1994-11-03
HU9502810D0 (en) 1995-11-28
IL109396A0 (en) 1994-07-31
HUT74173A (en) 1996-11-28
KR960701885A (ko) 1996-03-28
SK131995A3 (en) 1996-07-03
EP0696291B1 (de) 1998-08-19
EP0696291A1 (de) 1996-02-14
CA2161427A1 (en) 1994-11-10
FI955141A (fi) 1995-10-27
NO954317D0 (no) 1995-10-27
CN1043576C (zh) 1999-06-09
NZ265600A (en) 1996-09-25
US5750526A (en) 1998-05-12

Similar Documents

Publication Publication Date Title
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
IL108520A (en) 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HK1047098A1 (en) Tri-aryl acid derivatives as ppar receptor ligands.
PL338181A1 (en) Novel chemical compounds
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
HUP9904317A2 (hu) 1-Hidroxi-2-piridonok alkalmazása bőrbetegségek kezelésére alkalmas gyógyászati készítmények előállítására
HK1115728A1 (en) Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
GR3035956T3 (en) Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same
IL109396A (en) PYRIDO £1,2,3-de| QUINOXALINE-2,3- DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION
ES8504189A1 (es) Un compuesto de pirazol (3,4-b) piridina.
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
IL112588A (en) 2-Substituted imidazo Ú1,2-a¾ quinoxalin-4(5h)-one derivatives their preparation and pharmaceutical compositions containing them
HUP0002132A2 (hu) Új arilpiperazinilalkil-3(2H)-piridazinon-vegyületek, eljárás előállításukra és hatóanyagként ilyen vegyületeket tartalmazó készítmények
DE60227506D1 (de) DIHYDROIMIDAZOi5,1-A -BETA-CARBOLIN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE ANWENDUNG ALS ARZNEIMITTEL
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
IL109398A (en) Benzo(f) quinoxalinedione derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ATE254608T1 (de) Substituierte 2,3-benzodiazepinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische präparate sowie ihre verwendung
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void